Börse:
16,494€
-2,30%
Echtzeit-Aktienkurs Heron Therapeutics
Bid:
16,246€
Ask:
16,742€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 1,29 Mrd. EUR (78,17 Mio. x 16,494€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 507,52 | 34,64 | 16,64 |
| KGV | - | - | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Heron Therapeutics Aktie
Börsenkurse Heron Therapeutics
| Lang & Schwarz | 16,386€ | 729 | 16,518€ | 729 | 16,452€ | -3,35% |
| Euro Indikation | 16,246€ | 0 | 16,742€ | 0 | 16,494€ | -2,30% |
| Börse Stuttgart | 16,246€ | 0 | 16,742€ | 0 | 16,494€ | -0,37% |
| Dollar Indikation | 18,261$ | 0 | 18,752$ | 0 | 18,507$ | -3,61% |
Fundamentaldaten der Heron Therapeutics Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 77,47 Mio. | -178,84 Mio. | -178,84 Mio. | -2,44 | 0,00% | - | 16,64 |
| 2017 | 30,77 Mio. | -197,48 Mio. | -197,48 Mio. | -3,65 | 0,00% | - | 34,64 |
| 2016 | 1,28 Mio. | -173,14 Mio. | -173,14 Mio. | -4,57 | 0,00% | - | 507,52 |
Profil der Heron Therapeutics Aktie
Heron Therapeutics, Inc. is a biotechnology company develops pharmaceutical products for patients suffering from cancer or pain. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its primary products are SUSTOL, HTX-019 and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bioerodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen